FDA says manufacturing delays are constraining EpiPen supply

FAN Editor

The U.S. Food and Drug Administration added Mylan‘s EpiPen to its list of drugs in shortage on Wednesday, saying that manufacturing delays were creating intermittent supply constraints of the emergency allergy treatment.

The FDA said the status of Epipen, a lower dose version called EpiPen Jr, and Mylan’s own generic versions of those products were currently available, but that “supply levels may vary across wholesalers and pharmacies.”

Free America Network Articles

Leave a Reply

Next Post

Match CEO: Single people want to keep their dating lives separate from Facebook

Online dating firm Match isn’t worried about Facebook encroaching on the business for one key reason — people don’t want to mix their online dating life with the friends-and-family-first Facebook, according to Match CEO Mandy Ginsberg. “The vast majority of singles would not want to use Facebook for dating primarily […]